Incorrect username and/or password, please try again or click to reset.

Class 4 Medicines Notification: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets, EL(25)A/01

2025-01-09 11:10:43 (12 day(s) ago)

Summary

Bristol Laboratories Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the batches in the table for Rabeprazole sodium 10mg and 20mg gastro-resistant tablets do not contain the most up to date safet…

Read full MHRA article

Respond to this alert